Loading insider details...
Beta
Latest Form 4 (Sep 9, 2026): Sale of 38,500 TRDA shares, $273.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 9, 2026 | Entrada Therapeutics, Inc. (TRDA) | Sale | 38,500 | $273.7K |
| Sep 3, 2026 | Entrada Therapeutics, Inc. (TRDA) | Sale | 29,088 | $205.4K |
| Aug 31, 2026 | Entrada Therapeutics, Inc. (TRDA) | Sale | 38,922 | $280.2K |
| Aug 27, 2026 | Entrada Therapeutics, Inc. (TRDA) | Sale | 21,623 | $158.7K |
| Dec 4, 2025 | Werewolf Therapeutics, Inc. (HOWL) | Sale | 59,277 | $52.8K |
| Dec 1, 2025 | Werewolf Therapeutics, Inc. (HOWL) | Sale | 60,733 | $59.5K |
| Nov 25, 2025 | Werewolf Therapeutics, Inc. (HOWL) | Sale | 64,331 | $53.4K |
| Nov 20, 2025 | Werewolf Therapeutics, Inc. (HOWL) | Sale | 52,627 | $48.9K |
| Nov 18, 2025 | Werewolf Therapeutics, Inc. (HOWL) | Sale | 90,951 | $89.1K |
| Nov 13, 2025 | Werewolf Therapeutics, Inc. (HOWL) | Sale | 68,480 | $76.0K |